Cargando…
Taking cognizance of the risks associated with COVID-19, vaccine, and treatment in liver transplant recipients – A commentary on “The urgency of the Covid-19 vaccine in liver transplantation patients: What, how, and when?” [Int. J. Surg. 100 (Suppl) (2022) 106492)]
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IJS Publishing Group Ltd. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398562/ https://www.ncbi.nlm.nih.gov/pubmed/36028139 http://dx.doi.org/10.1016/j.ijsu.2022.106823 |
_version_ | 1784772350206541824 |
---|---|
author | MohanaSundaram, ArunSundar Thukani Sathanantham, Shanmugarajan Velayutham, Ravichandiran |
author_facet | MohanaSundaram, ArunSundar Thukani Sathanantham, Shanmugarajan Velayutham, Ravichandiran |
author_sort | MohanaSundaram, ArunSundar |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9398562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | IJS Publishing Group Ltd. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93985622022-08-24 Taking cognizance of the risks associated with COVID-19, vaccine, and treatment in liver transplant recipients – A commentary on “The urgency of the Covid-19 vaccine in liver transplantation patients: What, how, and when?” [Int. J. Surg. 100 (Suppl) (2022) 106492)] MohanaSundaram, ArunSundar Thukani Sathanantham, Shanmugarajan Velayutham, Ravichandiran Int J Surg Commentary IJS Publishing Group Ltd. Published by Elsevier Ltd. 2022-09 2022-08-24 /pmc/articles/PMC9398562/ /pubmed/36028139 http://dx.doi.org/10.1016/j.ijsu.2022.106823 Text en © 2022 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary MohanaSundaram, ArunSundar Thukani Sathanantham, Shanmugarajan Velayutham, Ravichandiran Taking cognizance of the risks associated with COVID-19, vaccine, and treatment in liver transplant recipients – A commentary on “The urgency of the Covid-19 vaccine in liver transplantation patients: What, how, and when?” [Int. J. Surg. 100 (Suppl) (2022) 106492)] |
title | Taking cognizance of the risks associated with COVID-19, vaccine, and treatment in liver transplant recipients – A commentary on “The urgency of the Covid-19 vaccine in liver transplantation patients: What, how, and when?” [Int. J. Surg. 100 (Suppl) (2022) 106492)] |
title_full | Taking cognizance of the risks associated with COVID-19, vaccine, and treatment in liver transplant recipients – A commentary on “The urgency of the Covid-19 vaccine in liver transplantation patients: What, how, and when?” [Int. J. Surg. 100 (Suppl) (2022) 106492)] |
title_fullStr | Taking cognizance of the risks associated with COVID-19, vaccine, and treatment in liver transplant recipients – A commentary on “The urgency of the Covid-19 vaccine in liver transplantation patients: What, how, and when?” [Int. J. Surg. 100 (Suppl) (2022) 106492)] |
title_full_unstemmed | Taking cognizance of the risks associated with COVID-19, vaccine, and treatment in liver transplant recipients – A commentary on “The urgency of the Covid-19 vaccine in liver transplantation patients: What, how, and when?” [Int. J. Surg. 100 (Suppl) (2022) 106492)] |
title_short | Taking cognizance of the risks associated with COVID-19, vaccine, and treatment in liver transplant recipients – A commentary on “The urgency of the Covid-19 vaccine in liver transplantation patients: What, how, and when?” [Int. J. Surg. 100 (Suppl) (2022) 106492)] |
title_sort | taking cognizance of the risks associated with covid-19, vaccine, and treatment in liver transplant recipients – a commentary on “the urgency of the covid-19 vaccine in liver transplantation patients: what, how, and when?” [int. j. surg. 100 (suppl) (2022) 106492)] |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398562/ https://www.ncbi.nlm.nih.gov/pubmed/36028139 http://dx.doi.org/10.1016/j.ijsu.2022.106823 |
work_keys_str_mv | AT mohanasundaramarunsundar takingcognizanceoftherisksassociatedwithcovid19vaccineandtreatmentinlivertransplantrecipientsacommentaryontheurgencyofthecovid19vaccineinlivertransplantationpatientswhathowandwhenintjsurg100suppl2022106492 AT thukanisathananthamshanmugarajan takingcognizanceoftherisksassociatedwithcovid19vaccineandtreatmentinlivertransplantrecipientsacommentaryontheurgencyofthecovid19vaccineinlivertransplantationpatientswhathowandwhenintjsurg100suppl2022106492 AT velayuthamravichandiran takingcognizanceoftherisksassociatedwithcovid19vaccineandtreatmentinlivertransplantrecipientsacommentaryontheurgencyofthecovid19vaccineinlivertransplantationpatientswhathowandwhenintjsurg100suppl2022106492 |